Correlation Between Medicure and OWC Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Medicure and OWC Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medicure and OWC Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medicure and OWC Pharmaceutical Research, you can compare the effects of market volatilities on Medicure and OWC Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medicure with a short position of OWC Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medicure and OWC Pharmaceutical.

Diversification Opportunities for Medicure and OWC Pharmaceutical

-0.29
  Correlation Coefficient

Very good diversification

The 3 months correlation between Medicure and OWC is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Medicure and OWC Pharmaceutical Research in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OWC Pharmaceutical and Medicure is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medicure are associated (or correlated) with OWC Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OWC Pharmaceutical has no effect on the direction of Medicure i.e., Medicure and OWC Pharmaceutical go up and down completely randomly.

Pair Corralation between Medicure and OWC Pharmaceutical

Assuming the 90 days horizon Medicure is expected to under-perform the OWC Pharmaceutical. But the pink sheet apears to be less risky and, when comparing its historical volatility, Medicure is 77.21 times less risky than OWC Pharmaceutical. The pink sheet trades about -0.03 of its potential returns per unit of risk. The OWC Pharmaceutical Research is currently generating about 0.34 of returns per unit of risk over similar time horizon. If you would invest  0.00  in OWC Pharmaceutical Research on September 12, 2024 and sell it today you would earn a total of  0.01  from holding OWC Pharmaceutical Research or generate 9.223372036854776E16% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Medicure  vs.  OWC Pharmaceutical Research

 Performance 
       Timeline  
Medicure 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medicure has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's forward-looking indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.
OWC Pharmaceutical 

Risk-Adjusted Performance

26 of 100

 
Weak
 
Strong
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in OWC Pharmaceutical Research are ranked lower than 26 (%) of all global equities and portfolios over the last 90 days. Even with relatively fragile fundamental indicators, OWC Pharmaceutical reported solid returns over the last few months and may actually be approaching a breakup point.

Medicure and OWC Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Medicure and OWC Pharmaceutical

The main advantage of trading using opposite Medicure and OWC Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medicure position performs unexpectedly, OWC Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OWC Pharmaceutical will offset losses from the drop in OWC Pharmaceutical's long position.
The idea behind Medicure and OWC Pharmaceutical Research pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Money Managers
Screen money managers from public funds and ETFs managed around the world
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years